MiRNA Sequencing and Assay Market projected to reach USD USD 828.8 Million by 2030, growing at a CAGR of 13.3% during the forecast period of 2023-2030 - a comprehensive study by MarketDigi...
Maravai LifeSciences Holdings, Inc. - Class A common stock (MRVI)
Company Research
Source: Yahoo! Finance
Richmond, Feb. 07, 2024 (GLOBE NEWSWIRE) -- According to a research report MiRNA Sequencing and Assay Market ” , by Product Type (Library Preparation, Consumables, Others), Technology (Sequencing by Synthesis, Nanopore, Ion Semiconductor Sequencing, Others), Application (Autoimmune Diseases, Polyglutamine Diseases, Cancer Diseases, schizophrenia, Others ), End User (Research Institute, Clinical Laboratory, CRO, Others ) and Region - Global Forecast to 2030. Global MiRNA Sequencing and Assay Market Report Scope: Report Details Market size value in 2023 USD 305.3 Million Market size value in 2030 USD USD 828.8 Million CAGR (2023-2030) Forecast Period 2023–2030 Historic Data Forecast Units Value (USD Million/USD Billion) Segments Covered Product Type Technology Application , End User and Region Geographies Covered North America, Europe, Asia Pacific, and RoW Maravai LifeSciences, Abcam Limited Sample of Companies Covered HTG Molecular Diagnostic
Show less
Read more
Impact Snapshot
Event Time:
MRVI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRVI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRVI alerts
High impacting Maravai LifeSciences Holdings, Inc. - Class A common stock news events
Weekly update
A roundup of the hottest topics
MRVI
News
- TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production [Yahoo! Finance]Yahoo! Finance
- TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance ProductionBusiness Wire
- Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024GlobeNewswire
- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $15.00 price target on the stock.MarketBeat
- Should You Sell Maravai LifeSciences (MRVI)? [Yahoo! Finance]Yahoo! Finance
MRVI
Earnings
- 2/22/24 - Beat
MRVI
Sec Filings
- 4/25/24 - Form ARS
- 4/25/24 - Form DEF
- 4/16/24 - Form 4
- MRVI's page on the SEC website